PS2: Patient experience data – The next steps towards medicines evaluation
Key points:
- Harmonisation is essential: the lack of standardisation across data collection and reporting methods for patient experience data (PED) continues to be a challenge. Greater alignment on methodologies is needed to ensure PED is used effectively in regulatory decisions
- Technological tools like Collaborare are paving the way for better data collection: web-based platforms that facilitate patient engagement in data collection are critical to addressing fragmentation and cultural barriers within patient organisations
To read more key points and the session summary, log in as a member or register for free using the links below.
How to read this journal article
Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to TOPRA members and registered users.
If you are a TOPRA member, or have already registered for limited free access, log in now (Option 1 below).
Not yet a member? You can either join TOPRA (Option 2 below) or register to view limited content for free (Option 3 below).
The Organisation for Professionals in Regulatory Affairs
- Contact us
- Copyright © 2015-2025 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved